{"id":32858,"date":"2020-08-10T10:06:13","date_gmt":"2020-08-10T09:06:13","guid":{"rendered":"https:\/\/www.biotechpharmasummit.com\/?page_id=32858"},"modified":"2021-03-19T09:18:10","modified_gmt":"2021-03-19T09:18:10","slug":"rochellys-diaz-heijtz","status":"publish","type":"page","link":"https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-2018-speakers\/rochellys-diaz-heijtz\/","title":{"rendered":"Rochellys Diaz Heijtz"},"content":{"rendered":"<div class=\"vgblk-rw-wrapper limit-wrapper\">\n<h2>Rochellys Diaz Heijtz<\/h2>\n<h4>Associate Professor and Group Leader in the Department of Neuroscience at Karolinska Institutet<\/h4>\n\t<p>Dr. Rochellys Diaz Heijtz is an Associate Professor and Group Leader in the Department of Neuroscience at Karolinska Institutet. Her research studies have a long-term goal of understanding the biological basis of neurodevelopmental disorders (ASD, ADHD), and how genes and the environment (prenatal and\/or early postnatal) together influence typical and atypical brain development and behavior.<\/p>\n<p>Her current research program includes basic studies investigating the influence of gut-derived microbial molecules, such as \u201cbacterial peptidoglycan fragments\u201d and their sensing molecules, on brain development and behavior, and clinical studies investigating the potential role of the gut microbiota in the pathophysiology of autism spectrum disorder (ASD) and other neurodevelopmental disorders.<\/p>\n\t\t\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Rochellys_Diaz_Heijtz_Karolinska-Institutet_BioTech_Pharma_Summit_profile.jpg\" alt=\"Rochellys_Diaz_Heijtz_Karolinska-Institutet_BioTech_Pharma_Summit_profile\" itemprop=\"image\" height=\"1224\" width=\"820\" title=\"Rochellys_Diaz_Heijtz_Karolinska-Institutet_BioTech_Pharma_Summit_profile\" onerror=\"this.style.display='none'\" sizes=\"(max-width: 768px) 100vw, 100vw\" srcset=\"data:image\/svg+xml;utf8,<svg%20xmlns=&quot;http:\/\/www.w3.org\/2000\/svg&quot;%20viewBox=&quot;0%200%20820%201224&quot;%20height=&quot;1224px&quot;%20width=&quot;820px&quot;\/>&#8221; data-srcset=&#8221;https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Rochellys_Diaz_Heijtz_Karolinska-Institutet_BioTech_Pharma_Summit_profile.jpg 820w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Rochellys_Diaz_Heijtz_Karolinska-Institutet_BioTech_Pharma_Summit_profile-201&#215;300.jpg 201w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Rochellys_Diaz_Heijtz_Karolinska-Institutet_BioTech_Pharma_Summit_profile-686&#215;1024.jpg 686w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Rochellys_Diaz_Heijtz_Karolinska-Institutet_BioTech_Pharma_Summit_profile-768&#215;1146.jpg 768w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Rochellys_Diaz_Heijtz_Karolinska-Institutet_BioTech_Pharma_Summit_profile-630&#215;940.jpg 630w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Rochellys_Diaz_Heijtz_Karolinska-Institutet_BioTech_Pharma_Summit_profile-420&#215;627.jpg 420w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Rochellys_Diaz_Heijtz_Karolinska-Institutet_BioTech_Pharma_Summit_profile-315&#215;470.jpg 315w&#8221;>\t\t\t\t\t\t\t\n<h3>\n\tTitle: Gut Microbes and the Developing Brain\n\t<\/h3>\n\t<ul>\n<li>Microbiota influence brain development and behavior<\/li>\n<li>Commensal bacteria-derived products can be translocated into the brain under normal conditions and influence the developing brain<\/li>\n<li>Discussing novel roles of bacterial peptidoglycan sensing molecules on brain development and behavior<\/li>\n<\/ul>\n\t<a href=\"\" target=\"_self\" role=\"button\" rel=\"noopener noreferrer\">\n\t\t\t\t\tPresentation not available\n\t<\/a>\n<h4>\n\t\t\t<a href=\"#\" title=\"On the Web\" target=\"_self\" rel=\"noopener noreferrer\">\n\tOn the Web\n\t\t\t<\/a>\n\t<\/h4>\n\t<p><a href=\"https:\/\/ki.se\/\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/ki.se\/<\/a><\/p>\n<h4>\n\t\t\t<a href=\"#\" title=\"On LinkedIn\" target=\"_self\" rel=\"noopener noreferrer\">\n\tOn LinkedIn\n\t\t\t<\/a>\n\t<\/h4>\n\t<p><a href=\"https:\/\/www.linkedin.com\/in\/rochellys-heijtz-57481358\/\" target=\"_blank\" rel=\"noopener noreferrer\">Visit Profile<\/a><\/p>\n<\/div><!-- .vgblk-rw-wrapper -->","protected":false},"excerpt":{"rendered":"<p>Rochellys Diaz Heijtz Associate Professor and Group Leader in the Department of Neuroscience at Karolinska Institutet Dr. Rochellys Diaz Heijtz is an Associate Professor and Group Leader in the Department of Neuroscience at Karolinska Institutet. Her research studies have a long-term goal of understanding the biological basis of neurodevelopmental disorders (ASD, ADHD), and how genes&#8230;<\/p>\n","protected":false},"author":1,"featured_media":32005,"parent":32856,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"inline_featured_image":false,"footnotes":""},"class_list":["post-32858","page","type-page","status-publish","has-post-thumbnail","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.2 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Rochellys Diaz Heijtz &#8226; BioTech Pharma Summit<\/title>\n<meta name=\"description\" content=\"Dr. Rochellys Diaz Heijtz is an Associate Professor and Group Leader in the Department of Neuroscience at Karolinska Institutet.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-2018-speakers\/rochellys-diaz-heijtz\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Rochellys Diaz Heijtz &#8226; BioTech Pharma Summit\" \/>\n<meta property=\"og:description\" content=\"Dr. Rochellys Diaz Heijtz is an Associate Professor and Group Leader in the Department of Neuroscience at Karolinska Institutet.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-2018-speakers\/rochellys-diaz-heijtz\/\" \/>\n<meta property=\"og:site_name\" content=\"BioTech Pharma Summit\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/biotechpharmasummit\/\" \/>\n<meta property=\"article:modified_time\" content=\"2021-03-19T09:18:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Rochellys_Diaz_Heijtz_Karolinska-Institutet_BioTech_Pharma_Summit.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"900\" \/>\n\t<meta property=\"og:image:height\" content=\"900\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@biotechsummit\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-2018-speakers\/rochellys-diaz-heijtz\/\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-2018-speakers\/rochellys-diaz-heijtz\/\",\"name\":\"Rochellys Diaz Heijtz &#8226; BioTech Pharma Summit\",\"isPartOf\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-2018-speakers\/rochellys-diaz-heijtz\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-2018-speakers\/rochellys-diaz-heijtz\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Rochellys_Diaz_Heijtz_Karolinska-Institutet_BioTech_Pharma_Summit.jpg\",\"datePublished\":\"2020-08-10T09:06:13+00:00\",\"dateModified\":\"2021-03-19T09:18:10+00:00\",\"description\":\"Dr. Rochellys Diaz Heijtz is an Associate Professor and Group Leader in the Department of Neuroscience at Karolinska Institutet.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-2018-speakers\/rochellys-diaz-heijtz\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-2018-speakers\/rochellys-diaz-heijtz\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-2018-speakers\/rochellys-diaz-heijtz\/#primaryimage\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Rochellys_Diaz_Heijtz_Karolinska-Institutet_BioTech_Pharma_Summit.jpg\",\"contentUrl\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Rochellys_Diaz_Heijtz_Karolinska-Institutet_BioTech_Pharma_Summit.jpg\",\"width\":900,\"height\":900},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-2018-speakers\/rochellys-diaz-heijtz\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.biotechpharmasummit.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Gut-Brain Axis 2018 Speakers\",\"item\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-2018-speakers\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Rochellys Diaz Heijtz\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#website\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/\",\"name\":\"BioTech Pharma Summit\",\"description\":\"The Tomorrow&#039;s healthcare congress\",\"publisher\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.biotechpharmasummit.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#organization\",\"name\":\"EPM Group\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/B_2_Logo_BioTech_Pharma_Summit_Porto.png\",\"contentUrl\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/B_2_Logo_BioTech_Pharma_Summit_Porto.png\",\"width\":2000,\"height\":2000,\"caption\":\"EPM Group\"},\"image\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/biotechpharmasummit\/\",\"https:\/\/x.com\/biotechsummit\",\"https:\/\/www.instagram.com\/biotechpharmasummit\/\",\"https:\/\/www.linkedin.com\/company\/biotech-pharma-summit\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Rochellys Diaz Heijtz &#8226; BioTech Pharma Summit","description":"Dr. Rochellys Diaz Heijtz is an Associate Professor and Group Leader in the Department of Neuroscience at Karolinska Institutet.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-2018-speakers\/rochellys-diaz-heijtz\/","og_locale":"en_US","og_type":"article","og_title":"Rochellys Diaz Heijtz &#8226; BioTech Pharma Summit","og_description":"Dr. Rochellys Diaz Heijtz is an Associate Professor and Group Leader in the Department of Neuroscience at Karolinska Institutet.","og_url":"https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-2018-speakers\/rochellys-diaz-heijtz\/","og_site_name":"BioTech Pharma Summit","article_publisher":"https:\/\/www.facebook.com\/biotechpharmasummit\/","article_modified_time":"2021-03-19T09:18:10+00:00","og_image":[{"width":900,"height":900,"url":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Rochellys_Diaz_Heijtz_Karolinska-Institutet_BioTech_Pharma_Summit.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_site":"@biotechsummit","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-2018-speakers\/rochellys-diaz-heijtz\/","url":"https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-2018-speakers\/rochellys-diaz-heijtz\/","name":"Rochellys Diaz Heijtz &#8226; BioTech Pharma Summit","isPartOf":{"@id":"https:\/\/www.biotechpharmasummit.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-2018-speakers\/rochellys-diaz-heijtz\/#primaryimage"},"image":{"@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-2018-speakers\/rochellys-diaz-heijtz\/#primaryimage"},"thumbnailUrl":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Rochellys_Diaz_Heijtz_Karolinska-Institutet_BioTech_Pharma_Summit.jpg","datePublished":"2020-08-10T09:06:13+00:00","dateModified":"2021-03-19T09:18:10+00:00","description":"Dr. Rochellys Diaz Heijtz is an Associate Professor and Group Leader in the Department of Neuroscience at Karolinska Institutet.","breadcrumb":{"@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-2018-speakers\/rochellys-diaz-heijtz\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-2018-speakers\/rochellys-diaz-heijtz\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-2018-speakers\/rochellys-diaz-heijtz\/#primaryimage","url":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Rochellys_Diaz_Heijtz_Karolinska-Institutet_BioTech_Pharma_Summit.jpg","contentUrl":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/07\/Rochellys_Diaz_Heijtz_Karolinska-Institutet_BioTech_Pharma_Summit.jpg","width":900,"height":900},{"@type":"BreadcrumbList","@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-2018-speakers\/rochellys-diaz-heijtz\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.biotechpharmasummit.com\/"},{"@type":"ListItem","position":2,"name":"Gut-Brain Axis 2018 Speakers","item":"https:\/\/www.biotechpharmasummit.com\/index.php\/gut-brain-axis-2018-speakers\/"},{"@type":"ListItem","position":3,"name":"Rochellys Diaz Heijtz"}]},{"@type":"WebSite","@id":"https:\/\/www.biotechpharmasummit.com\/#website","url":"https:\/\/www.biotechpharmasummit.com\/","name":"BioTech Pharma Summit","description":"The Tomorrow&#039;s healthcare congress","publisher":{"@id":"https:\/\/www.biotechpharmasummit.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.biotechpharmasummit.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.biotechpharmasummit.com\/#organization","name":"EPM Group","url":"https:\/\/www.biotechpharmasummit.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.biotechpharmasummit.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/B_2_Logo_BioTech_Pharma_Summit_Porto.png","contentUrl":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/B_2_Logo_BioTech_Pharma_Summit_Porto.png","width":2000,"height":2000,"caption":"EPM Group"},"image":{"@id":"https:\/\/www.biotechpharmasummit.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/biotechpharmasummit\/","https:\/\/x.com\/biotechsummit","https:\/\/www.instagram.com\/biotechpharmasummit\/","https:\/\/www.linkedin.com\/company\/biotech-pharma-summit\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages\/32858","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/comments?post=32858"}],"version-history":[{"count":4,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages\/32858\/revisions"}],"predecessor-version":[{"id":36135,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages\/32858\/revisions\/36135"}],"up":[{"embeddable":true,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages\/32856"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/media\/32005"}],"wp:attachment":[{"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/media?parent=32858"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}